Rethink radiotherapy – BIGART 2017

C. Grau,M. Høyer,P. Poulsen,L. Muren,S. Korreman,K. Tanderup,J. Lindegaard,J. Alsner,J. Overgaard

DOI: https://doi.org/10.1080/0284186X.2017.1371326

IF: 4.311

2017-11-02

Acta Oncologica

Abstract:The present issue of Acta Oncologica contains studies presented at the 15th Acta Oncologica Symposium, held in Aarhus, Denmark on June 13–16, 2017. The symposium was dedicated to aspects of Biology-Guided Adaptive Radiotherapy (BiGART) and attracted more than 200 physicians, physicists, radiobiologists and other scientists with an active interest in this specific area. Acta Oncologica has sponsored scientific symposia since the late 80s. The aim of these meetings has been to focus on oncological issues of emerging interest, preferably with a multidisciplinary and multi-professional approach. The current series of Acta Oncologica meetings with focus on radiotherapy (RT) have encompassed stereotactic body RT (SBRT) [1], image-guided RT [2], particle RT [3] and BiGART [4–6], all reflecting development in RT during the last decennium within the fields of treatment planning [7–12], (biological) imaging [13–33], adoptive RT, [34–44] particle therapy [45–50], clinical outcome [51–63], quality assurance [64,65], and other important factors [66–72]. The aim of BiGART is treatment adaptation in time and space based on biological and anatomical features, maximizing the therapeutic ratio for each individual patient. Key topics for the BiGART2017 conference included: